Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-26-188175
Filing Date
2026-04-29
Accepted
2026-04-28 19:17:43
Documents
7
Period of Report
2026-04-28

Document Format Files

Seq Description Document Type Size
1 6-K sndl-6-k-2026_q1.htm 6-K 23724
2 EX-99.1 sndl-ex99_1.htm EX-99.1 1929745
3 EX-99.2 sndl-ex99_2.htm EX-99.2 1245154
4 EX-99.3 sndl-ex99_3.htm EX-99.3 24615
5 EX-99.4 sndl-ex99_4.htm EX-99.4 24828
6 GRAPHIC img260723042_0.jpg GRAPHIC 15922
7 GRAPHIC img261646563_0.jpg GRAPHIC 15922
  Complete submission text file 0001193125-26-188175.txt   3293461
Mailing Address 17220 STONY PLAIN ROAD NW SUITE 101 EDMONTON Canada (Federal Level)
Business Address 17220 STONY PLAIN ROAD NW SUITE 101 EDMONTON Canada (Federal Level) 17809449994
SNDL Inc. (Filer) CIK: 0001766600 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39005 | Film No.: 26909902
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)